Metformina: stary lek w nowej aplikacji

作者: Anna Dmoszyńska , Monika Podhorecka , Krzysztof Giannopoulos

DOI: 10.1016/J.ACHAEM.2016.04.001

关键词:

摘要: Metformin is a biguanide derivative that was synthesized in the 20's of last century. The main mechanism action ability to inhibit hepatic gluconeogenesis and trigger glucose uptake skeletal muscles. not only an antihyperglycaemic drug but also has protective effects on endothelium cells. In decade, many publications displayed metformin can reduce risk cancer diabetic patients demonstrated effect against certain types cancer. this review article, we discuss known mechanisms anticancer its beneficial role as vascular agent.

参考文章(51)
S Jagannathan, M A Y Abdel-Malek, E Malek, N Vad, T Latif, K C Anderson, J J Driscoll, Pharmacologic screens reveal metformin that suppresses GRP78-dependent autophagy to enhance the anti-myeloma effect of bortezomib Leukemia. ,vol. 29, pp. 2184- 2191 ,(2015) , 10.1038/LEU.2015.157
Mustafa Kinaan, Hong Ding, Chris R. Triggle, Metformin: An Old Drug for the Treatment of Diabetes but a New Drug for the Protection of the Endothelium. Medical Principles and Practice. ,vol. 24, pp. 401- 415 ,(2015) , 10.1159/000381643
Bernd Kowall, Andreas Stang, Wolfgang Rathmann, Karel Kostev, No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK. Pharmacoepidemiology and Drug Safety. ,vol. 24, pp. 865- 874 ,(2015) , 10.1002/PDS.3823
Olga Moiseeva, Xavier-Deschênes-Simard, Michael Pollak, Gerardo Ferbeyre, Metformin, aging and cancer. Aging (Albany NY). ,vol. 5, pp. 330- 331 ,(2013) , 10.18632/AGING.100556
Ting Yang, Yuan Yang, Shengchun Liu, Association between Metformin Therapy and Breast Cancer Incidence and Mortality: Evidence from a Meta-Analysis. Journal of Breast Cancer. ,vol. 18, pp. 264- 270 ,(2015) , 10.4048/JBC.2015.18.3.264
Konrad H. Stopsack, David R. Ziehr, Jennifer R. Rider, Edward L. Giovannucci, Metformin and prostate cancer mortality: a meta-analysis Cancer Causes & Control. ,vol. 27, pp. 105- 113 ,(2016) , 10.1007/S10552-015-0687-0
Claudia Becker, Susan S. Jick, Christoph R. Meier, Michael Bodmer, No evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study BMC Cancer. ,vol. 15, pp. 719- 719 ,(2015) , 10.1186/S12885-015-1719-6
Silvia Bruno, Bernardetta Ledda, Claudya Tenca, Silvia Ravera, Anna Maria Orengo, Andrea Nicola Mazzarello, Elisa Pesenti, Salvatore Casciaro, Omar Racchi, Fabio Ghiotto, Cecilia Marini, Gianmario Sambuceti, Andrea DeCensi, Franco Fais, Metformin inhibits cell cycle progression of B-cell chronic lymphocytic leukemia cells Oncotarget. ,vol. 6, pp. 22624- 22640 ,(2015) , 10.18632/ONCOTARGET.4168
Yi Zu, Ling Liu, Mary Y.K. Lee, Cheng Xu, Yan Liang, Ricky Y. Man, Paul M. Vanhoutte, Yu Wang, SIRT1 Promotes Proliferation and Prevents Senescence Through Targeting LKB1 in Primary Porcine Aortic Endothelial Cells Circulation Research. ,vol. 106, pp. 1384- 1393 ,(2010) , 10.1161/CIRCRESAHA.109.215483
Nananda F. Col, Leslie Ochs, Vicky Springmann, Aaron K. Aragaki, Rowan T. Chlebowski, Metformin and breast cancer risk: a meta-analysis and critical literature review. Breast Cancer Research and Treatment. ,vol. 135, pp. 639- 646 ,(2012) , 10.1007/S10549-012-2170-X